Natural adjuvants: Endogenous activators of dendritic cells

Nature Medicine

Volumn 5, Issue 11, 1999, Pages 1249-1255

  Gallucci, Stefania ^a   Lolkema, Martijn ^a   Matzinger, Polly ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CELL DEATH; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GRAFT REJECTION; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SCID MOUSE; SIGNAL TRANSDUCTION; STRESS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; APOPTOSIS; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, SCID; NECROSIS;

EID: 0032695108     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/15200     Document Type: Article

References (49)

1. Steinman, R. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271-296 (1991).
2. Cella, M., Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9, 10-16 (1997).
3. Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
4. Pierre, P. et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388, 787-792 (1997).
5. Janeway, C.J. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54, 1-13 (1989).
6. Medzhitov, R. & Janeway, C.A. Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91, 295-298 (1997).
7. Roake, J. et al. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 181, 2237-2247 (1995).
8. Sallusto, F., Cella, M., Danieli, C. & Lanzavecchia, A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400 (1995).
9. Slupsky, P. et al. Activated platelets induce tissue factor expression on human umbelical vein endothelial cells by ligation of CD40. Thromb. Haemost. 80, 1008-1014 (1998).
10. Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045 (1994).
11. Matzinger, P. An innate sense of danger. Semin. Immunol. 10, 399-415 (1998).
12. Sallusto, F. & Lanzavecchia. A. Efficient presentation of soluble antigen by cultured human dendritic is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109-1118 (1994).
13. Inaba, K. et al. Generation of large numbers of dendritic cells from mouse bone marrow culture supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693-1702 (1992).
14. Inaba, K. et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180, 1849-1860 (1994).
15. Yahraus, T., Chandra, S., Legendre, L. & Low, P.S. Evidence for a mechanically induced oxidative burst. Plant Physiol. 109, 1259-1266 (1995).
16. Voll, R. et al. Immunosuppressive effects of apoptotic cells. Nature 390, 350-351 (1997).
17. Fadok, V. et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101, 890-898 (1998).
18. Rubartelli, A., Poggi, A. & Zocchi, M.R. The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium. Eur. J. Immunol. 27, 1893-1900 (1997).
19. Albert, M., Sauter, B. & Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392, 86-89 (1998).
20. Inaba, K. et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188, 2163-2173 (1998).
21. Kurts, C. et al. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184, 923-930 (1996).
22. Germain, R. & Margulies, D.H. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11, 403-450 (1993).
23. Bradley, J. Indirect T cell recognition in allograft rejection. Int. Rev. Immunol. 13, 245-255 (1996).
24. Sen, G. & Lengye, I.P. The interferon system. A bird's eye view of its biochemistry. J. Biol. Chem. 267, 5017-5020 (1992).
25. Pfeffer, L. et al. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res 58, 2489-2499 (1998).
26. Swensson, H., Johannisson, A., Nikkila, T., Alm, G.V. & Cederblad, B. The cell surface phenotype of human interferon-alpha producing cells as determined by flow cytometry. Scand. J. Immunol. 44, 164-172 (1996).
27. Chakrabarti, D. Hultgren, B. & Stewart, T.A. IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2. J. Immunol. 157, 522-528 (1996).
28. Luft, T. et al. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161, 1947-1953 (1998).
29. Gresser, I., Tovey, M.G., Bandu, M.E., Maury, C. & Brouty-Boye, D. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J. Exp. Med. 144, 1305-1315 (1976).
30. Lassila, O., Vainio, O. & Matzinger, P. Can B cells turn on virgin T cells? Nature 334, 253-255 (1988).
31. Ochsenbein, A.F. et al. Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl. Acad. Sci. USA 96, 2233-2238 (1999).
32. Ronchetti, A. et al. Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines. J. Immunol. 163, 130-136 (1999).
33. Harding, C., Heuser, J. & Stahl, P. Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding. Eur. J. Cell Biol. 35, 256-263 (1984).
34. Bartoccioni, E. et al. MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin. Exp. Immunol. 95, 166-172 (1994).
35. Mackay, C., Marston, W.L. & Dudler, L. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J. Exp. Med. 171, 801-817 (1990).
36. Tamura, Y., Peng, P., Liu, K., Daou, M. & Srivastava, P.K. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278, 117-120 (1997).
37. Ip, Y. et al. Dif, a dorsal-related gene that mediates an immune response in Drosophila. Cell 75, 753-763 (1993).
38. Lemaitre, B., Reichhart, J.M. & Hoffmann, J.A. Drosophila host defense: differential induction of antimicrobial peptide genes after infection by various classes of microorganisms. Proc. Natl. Acad. Sci. USA 94, 14614-14619 (1997).
39. Delledonne, M., Xia, Y., Dixon, R.A. & Lamb, C. Nitric oxide functions as a signal in plant disease resistance. Nature 394, 585-588 (1998).
40. Cole, W. Efforts to explain spontaneous regression of cancer. J. Surg. Oncol. 17, 201-209 (1981).
41. Land, W. et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 57 (1994).
42. Coley, W. The treatment of inoperable sarcoma with the mixed toxins of erysipelas and bacillus prodigiosus. JAMA 20, 389-395 (1898).
43. Devitt, A. et al. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392, 505-509 (1998).
44. Yang, R. et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395, 284-288 (1998).
45. Aliprantis, A. et al. Cell Activation and apoptosis by bacterial lipoproteins yhrough Toll-like receptor-2. Science 285, 736-739 (1999).
46. Cohen, O., Kinter, A. & Fauci, A.S. Host factors in the pathogenesis of HIV disease. Immunol. Rev. 159, 31-48 (1997).
47. Fingeroth, J. et al. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. USA 81, 4510-4514 (1984).
48. White, J. et al. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56, 27-35 (1989).
49. Joiner, K., Brown E.J. & Frank, M.M. Complement and bacteria: chemistry and biology in host defense. Annu. Rev. Immunol. 2, 461-491 (1984).